139 related articles for article (PubMed ID: 32358383)
1. Traditional Chinese medicine may reduce the dosage of systemic glucocorticoids in required patients with acute exacerbation of chronic obstructive pulmonary disease: Study protocol for a randomized placebo-controlled trial.
Zhao K; Chen K; Huang Q; Gao P; Zhang C; Yang H; Gan W; Xiao W; Sun Z; Xie X; Long K; Zhang S; Chen J
Medicine (Baltimore); 2020 May; 99(18):e20035. PubMed ID: 32358383
[TBL] [Abstract][Full Text] [Related]
2. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y
Trials; 2012 Apr; 13():40. PubMed ID: 22520863
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial.
Kong Q; Mo S; Wang W; Tang Z; Wei Y; Du Y; Liu B; Kong L; Lv Y; Dong J
Trials; 2020 Sep; 21(1):760. PubMed ID: 32883322
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
[TBL] [Abstract][Full Text] [Related]
5. Effect of sequential treatment with TCM syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and AECOPD risk window.
Jiansheng L; Haifeng W; Suyun L; Hailong Z; Xueqing Y; Xiaoyun Z; Fengsen L; Xianmei Z; Zikai S; Yimin M; Lijun M; Yijie Z; Guojun Z; Bingxiang T
Complement Ther Med; 2016 Dec; 29():109-115. PubMed ID: 27912934
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Xin Jia Xuan Bai Cheng Qi Decoction in treating acute exacerbation of chronic obstructive pulmonary disease: study protocol for a multicentre, randomised, controlled trial.
Jin J; Zhang H; Li D; Jing Y; Sun Z; Feng J; Zhang H; Zhang Y; Cui T; Lei X; Zhang J; Cheng Q; Li E
BMJ Open; 2019 Nov; 9(11):e030249. PubMed ID: 31784433
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial for prevention of acute exacerbation of stable chronic obstructive pulmonary disease with acupoint application of traditional Chinese medicine: Study protocol clinical trial (SPIRIT Compliant).
Zhang C; Yang H; Gan W; Chen J; Yang Y; Xiao W; Long K; Chen K; Huang Q; Gao P
Medicine (Baltimore); 2020 Mar; 99(10):e19396. PubMed ID: 32150085
[TBL] [Abstract][Full Text] [Related]
8. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
Zu Y; Li D; Lei X; Zhang H
Trials; 2019 Nov; 20(1):647. PubMed ID: 31775843
[TBL] [Abstract][Full Text] [Related]
9. Effects of Chinese Herbal Medicine on Acute Exacerbations of COPD: A Randomized, Placebo-Controlled Study.
Li J; Zhang H; Ruan H; Si Y; Sun Z; Liu H; Feng J; Wang Y; Li L; Bai L; Sun H
Int J Chron Obstruct Pulmon Dis; 2020; 15():2901-2912. PubMed ID: 33209019
[TBL] [Abstract][Full Text] [Related]
10. Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial.
Xia R; Fei Y; Zhang L; Jie Z; Fan X; Dai M; Moore M; Willcox M; Hu X; Francis N; Liang C; Fei G; Liu J
BMJ Open; 2023 Sep; 13(9):e070864. PubMed ID: 37775286
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.
Ding Z; Li X; Lu Y; Rong G; Yang R; Zhang R; Wang G; Wei X; Ye Y; Qian Z; Liu H; Zhu D; Zhou R; Zhu K; Ni R; Xia K; Luo N; Pei C
Respir Med; 2016 Dec; 121():39-47. PubMed ID: 27888990
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Zhang R; Zhu J; Liu Y; Li Y; Liu W; Zhang M; Chen B; Zhu S
Int J Chron Obstruct Pulmon Dis; 2020; 15():409-415. PubMed ID: 32161453
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.
Kong Q; Cao Y; Gao Z; Sun J; Zhang H; Du Y; Lv Y; Zhou S; Tang Z; Liu B; Dong J
Trials; 2022 Feb; 23(1):143. PubMed ID: 35164853
[TBL] [Abstract][Full Text] [Related]
14. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
Leuppi JD; Schuetz P; Bingisser R; Bodmer M; Briel M; Drescher T; Duerring U; Henzen C; Leibbrandt Y; Maier S; Miedinger D; Müller B; Scherr A; Schindler C; Stoeckli R; Viatte S; von Garnier C; Tamm M; Rutishauser J
JAMA; 2013 Jun; 309(21):2223-31. PubMed ID: 23695200
[TBL] [Abstract][Full Text] [Related]
15. Traditional Chinese medicine tonifying kidney therapy (Bu shen) for stable chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis.
Zhen G; Yingying L; Jingcheng D
Medicine (Baltimore); 2018 Dec; 97(52):e13701. PubMed ID: 30593141
[TBL] [Abstract][Full Text] [Related]
16. Traditional Chinese medicine classic herbal formula Xiaoqinglong decoction for acute exacerbation of chronic obstructive pulmonary disease: A systematic review protocol.
Zhen G; Jing J; Fengsen L
Medicine (Baltimore); 2018 Dec; 97(52):e13761. PubMed ID: 30593152
[TBL] [Abstract][Full Text] [Related]
17. [Clinical investigation on the related factors for the application of systemic glucocorticoids in patients with acute exacerbation of chronic obstructive pulmonary disease with carbon dioxide retention].
Jiao W; Zhang W; Zhang C; Liu Z; Gan Y; Peng Z; Yan G; Deng X; Xue Q; Wu J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1061-1066. PubMed ID: 33081891
[TBL] [Abstract][Full Text] [Related]
18. Preventive Effects of Qingfei Yihuo Capsules () on Air Pollution Associated Exacerbation of Chronic Obstructive Pulmonary Disease: A Single-blind, Randomized, Controlled Trial.
Hu WP; Wu XD; Li ZZ; Zhang J
Chin J Integr Med; 2020 Nov; 26(11):806-811. PubMed ID: 32876858
[TBL] [Abstract][Full Text] [Related]
19. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study.
Li SY; Li JS; Wang MH; Xie Y; Yu XQ; Sun ZK; Ma LJ; Zhang W; Zhang HL; Cao F; Pan YC
BMC Complement Altern Med; 2012 Oct; 12():197. PubMed ID: 23107470
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of salvational intervention with ICS/LABA for reducing chronic obstructive pulmonary disease exacerbation under severe air pollution (SIRCAP) in Beijing: protocol of a multi-center randomized controlled trial.
Zhou T; Zhong Y; Liao J; Wang G; Li X; Qian X; Xiang P; Chen X; Xu Z; Zhang F; Wang X; Wang S; Li X; Yu C; Zhang Y; Xia G; Dai L
BMC Pulm Med; 2019 Jan; 19(1):22. PubMed ID: 30683080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
